We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£102.00
It has never been this cheap. We have no record of a lower price.
£102 today · cheaper than every other day in the last 3 months
CRC Press Alzheimer's Disease Computational and Experimental Book
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 20 days · 20 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 20 days • 2 price levels
Price Analysis
Most common price: £102 (10 days, 50.0%)
Price range: £102 - £108
Price levels: 2 different prices over 20 days
Description
Key Features
This CRC Press reference book compiles recent advances in computational and experimental modeling for Alzheimer's disease management.
The text covers basic etiopathology and various in vitro and in vivo strategies used for disease intervention.
Learn how computer-aided drug design approaches help reduce costs and increase the efficiency of biological testing.
Review essential methods for screening anti-Alzheimer drugs and conducting biomarker analysis of disease inhibitors.
Explore the mechanistic aspects of neurodegeneration and the application of natural products as therapeutics.
Product Specifications
- Brand
- CRC Press
- Model
- 9781032530079
- Format
- hardcover
- ASIN
- 1032530073
- Domain
- Amazon UK
- Release Date
- 26 April 2024
- Listed Since
- 16 September 2023
Barcode
No barcode data available
Similar Products You Might Like
Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease
Elsevier
Pharmacological Mechanisms in Alzheimer's Therapeutics
Springer
Humana Biomarkers for Alzheimer's Disease Drug Development 2785
Humana
CRC Press - Molecular Biology of Alzheimer's Disease Book
CRC Press
Multi-Factorial Approach as a Therapeutic Strategy for the Management of Alzheimer’s Disease
Springer
Price unavailable
Nutraceuticals for Alzheimer's Disease: A Promising Therapeutic Approach (Nutritional Neurosciences)
Springer
Emerging Drugs and Targets for Alzheimer's Disease: Volume 2: Neuronal Plasticity (Drug Discovery Series)
Royal Society of Chemistry
A New Era in Alzheimer's Research: Pathogenesis, Prevention, and Treatment
Elsevier
The End of Alzheimer's: The Brain and Beyond
Elsevier
The Handbook of Alzheimer's Disease and Other Dementias: 1 (Blackwell Handbooks of Behavioral Neuroscience)
Wiley
Clinical Management of Early Alzheimer's Disease Handbook
Psychology Press
Alzheimer's Disease and Related Disorders: Etiology, Pathogenesis and Therapeutics
Wiley
Neuroprotection in Alzheimer's Disease
Elsevier
Clinical Diagnosis and Management of Alzheimer's Disease
CRC Press
Alzheimer's Disease Drug Development: Research and Development Ecosystem
Cambridge University Press
Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics
Springer
The Dementias: Diagnosis, Management, and Research
American Psychiatric Association Publishing
Emerging Drugs and Targets for Alzheimer's Disease: Volume 1: Beta-Amyloid (Drug Discovery Series)
Royal Society of Chemistry
Alzheimer's Disease: Advances in Genetics, Molecular and Cellular Biology
Springer
Stahl's Illustrated Alzheimer's Disease and Dementias Guide
Cambridge University Press
Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)
Humana
Progressive Cognitive Impairment & its Neuropathologic Correlates
Alzheimer’s Disease: Diagnosis and Treatment Guide
Springer
Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)
Humana